Stephanie Yacoub1, Kenneth Cadesky2, Robert F Casper3,4. 1. Present address: Department of Obstetrics and Gynecology, Saint Georges Hospital University Medical Center, Beirut, Lebanon. 2. TRIO Fertility, and Department of Obstetrics and Gynecology, University of Toronto, 655 Bay St, Suite 1101, Toronto, ON, M5G2K4, Canada. 3. TRIO Fertility, and Department of Obstetrics and Gynecology, University of Toronto, 655 Bay St, Suite 1101, Toronto, ON, M5G2K4, Canada. casper@lunenfeld.ca. 4. Lunenfeld-Tanenbaum Research Institute, Mount Sinai System, Toronto, ON, Canada. casper@lunenfeld.ca.
Abstract
BACKGROUND: To explore the efficacy of follitropin delta in ovarian stimulation of patients with the Rotterdam ESHRE/ASRM 2003 phenotypes of polycystic ovarian syndrome (PCOS) using a retrospective case series with an electronic file search in a reproductive medicine clinic. CASE PRESENTATION: Seventy-four patients with PCOS undergoing ovarian stimulation according to the individualized dosing algorithm of follitropin delta for in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI)/oocyte freezing were included. Follitropin delta resulted in a high number of pre-ovulatory follicles at the end of stimulation as expected in patients with PCOS. There was a large number of oocytes retrieved with an acceptable percentage of metaphase II (MII) oocytes. There were no cases of moderate or severe OHSS across all phenotypes. CONCLUSION: Follitropin delta, using the individualized dosing algorithm, appears to be a safe method of ovarian stimulation with a low risk of OHSS in PCOS patients without sacrificing successful stimulation outcomes.
BACKGROUND: To explore the efficacy of follitropin delta in ovarian stimulation of patients with the Rotterdam ESHRE/ASRM 2003 phenotypes of polycystic ovarian syndrome (PCOS) using a retrospective case series with an electronic file search in a reproductive medicine clinic. CASE PRESENTATION: Seventy-four patients with PCOS undergoing ovarian stimulation according to the individualized dosing algorithm of follitropin delta for in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI)/oocyte freezing were included. Follitropin delta resulted in a high number of pre-ovulatory follicles at the end of stimulation as expected in patients with PCOS. There was a large number of oocytes retrieved with an acceptable percentage of metaphase II (MII) oocytes. There were no cases of moderate or severe OHSS across all phenotypes. CONCLUSION: Follitropin delta, using the individualized dosing algorithm, appears to be a safe method of ovarian stimulation with a low risk of OHSS in PCOSpatients without sacrificing successful stimulation outcomes.
Authors: Evangelos G Papanikolaou; Cristina Pozzobon; Efstratios M Kolibianakis; Michel Camus; Herman Tournaye; Human M Fatemi; Andre Van Steirteghem; Paul Devroey Journal: Fertil Steril Date: 2006-01 Impact factor: 7.329
Authors: Panagiotis Drakopoulos; Christophe Blockeel; Dominic Stoop; Michel Camus; Michel de Vos; Herman Tournaye; Nikolaos P Polyzos Journal: Hum Reprod Date: 2016-01-02 Impact factor: 6.918
Authors: A J Goverde; A J B van Koert; M J Eijkemans; E A H Knauff; H E Westerveld; B C J M Fauser; F J Broekmans Journal: Hum Reprod Date: 2008-12-17 Impact factor: 6.918
Authors: D Fischer; C Reisenbüchler; S Rösner; J Haussmann; P Wimberger; M Goeckenjan Journal: Geburtshilfe Frauenheilkd Date: 2016-06 Impact factor: 2.915
Authors: Reshef Tal; David B Seifer; Moisey Khanimov; Henry E Malter; Richard V Grazi; Ben Leader Journal: Am J Obstet Gynecol Date: 2014-03-02 Impact factor: 8.661